This is a precaution to protect both your safety and recovery, and you may be able to donate once your condition improves
A: SEMALIX 7 TABLET are not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia type 2 (MEN2), type 1 diabetes, or a history of diabetic ketoacidosis
Medications such as Gaviscon double-action, Wind-Setler, containing dimeticone, and Alka-Seltzer, may provide relief for some individuals
Our published outcomes, in a 2025 JMIR Formative Research study, show an average 19.1% body weight loss at 12 months among active subscribers, with 77.7% achieving at least 10% weight loss
Gradual steps help your body adjust and keep the experience more comfortable